Dongwha, Novartis Korea sign OTC deal

Published: 2011-01-21 06:57:00
Updated: 2011-01-21 06:57:00
Dongwha Pharmaceutical and Novartis Korea recently established a strategic alliance to co-market the whole range of the latter’s over-the-counter (OTC) drugs in Korea.

These OTC medicines include Lamisil (terbinafine), Otribin (xylometazoline), Nicotine-L, Voltaren (diclofenac) and Theraflu.
...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.